New treatment study for enlarged prostate (BPH)
Treatments studied
Part of Kidney & urinary clinical trials.
This trial tests new treatment strategies for benign prostatic hyperplasia (BPH, an enlarged prostate) using a special MRI scan and a medication called finasteride. It aims to find better ways to manage symptoms and identify markers that predict response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your doctor has recommended finasteride for your BPH.
- Your PSA level was below 20 ng/mL in the last 6 months.
- You are willing to stay on your current medications for urinary symptoms.
- You have not had blood clots (like DVT or pulmonary embolism) before.
- You have never been diagnosed with prostate cancer or precancerous changes.
- You have not had radiation to your pelvis.
- You are not currently being treated for bladder cancer with medications placed into the bladder.
- You have not taken medications like azacitidine, decitabine, or hydralazine.
- You are not taking warfarin (a blood thinner).
- You have not taken finasteride or dutasteride in the last year.
- You have not been diagnosed with diabetes.
- You have not been diagnosed with a neurodegenerative disease (like Parkinson's or Alzheimer's).
- You have no history of allergy to IV iron supplements.
- You are not taking cholestyramine (a cholesterol-lowering drug).
- You can have an MRI without metal implants, pacemaker, or severe claustrophobia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a prostate test marker to understand who is more likely to benefit from 5-ARI medicines such as finasteride or dutasteride. If you have enlarged prostate symptoms and are getting a biopsy, the results may help doctors better choose or interpret 5-ARI treatment.
This trial tests a new, once-daily tablet (H077) compared to the standard medicine silodosin for treating symptoms of an enlarged prostate. It aims to see if the new medicine works as well and is safe.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
This trial tests whether a drug called adalimumab (a TNF blocker) can improve symptoms of an enlarged prostate. It is for men aged 45-80 with a large prostate and bothersome urinary symptoms who have not used this type of medication before.
This trial tests two new drugs (QLC5508 and QLH12016) alone or together with other treatments for prostate cancer that has spread to other parts of the body. It may be an option if standard treatments have stopped working or caused side effects.
This trial tests a new minimally invasive treatment device called the ALPFA GRAIL System to see if it safely and effectively reduces urinary symptoms caused by an enlarged prostate. The procedure aims to improve urinary flow and reduce bothersome symptoms like frequent urination.
Hear when a new Lower Urinary Track Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.